Skip to content

Investigator

Ping Wang

HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES · funded by NIDDK, NIAID, NIGMS

Companies
5

Resolved onto their grants.

Grants
6

Federal awards on file.

Non-dilutive funding
$3.3M

Summed across those awards.

First award
Feb 1, 2004

Latest May 1, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R03

    Targeted nanotheranostics for beta-cell protection in type 1 diabetes

    $157k

    May 1, 2026NIDDKHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11360436 (opens the source filing in a new tab)

  2. U01

    Ghrelin as Radiation Countermeasure: Mechanism of Its Action

    $586k

    Dec 5, 2024NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11241165 (opens the source filing in a new tab)

  3. U01

    Mechanisms of Radiation-Induced Innate Immune Dysfunction and Its Countermeasures

    $767k

    Jul 21, 2022NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11093579 (opens the source filing in a new tab)

  4. U01

    Mechanisms of Radiation-Induced Innate Immune Dysfunction and Its Countermeasures

    $775k

    Jul 21, 2022NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11362259 (opens the source filing in a new tab)

  5. R35

    Novel Approaches to Maintaining Organ Function in Sepsis

    $509k

    Jun 1, 2016NIGMSFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11129760 (opens the source filing in a new tab)

  6. R01

    Improvement of Organ Function after Severe Hypovolemia

    $531k

    Feb 1, 2004NHLBIFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11249607 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources